Company Directory / biotechnology

PrivateFor profitbiotechnologySan Diego, United States
Endeavor BioMedicines develops new treatments targeting the underlying causes of pulmonary fibrosis.
Size
11-50 people: larger than 33% of companies with a size listed
Age
8 years old.
Reach
Website ranked #4,168,895 in the world for traffic, about 2k visits a month.
BiotechnologyHealth CareMedical
Funding, as listed
$296M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Endeavor BioMedicines, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
Endeavor BioMedicines raised $132.5 million in an oversubscribed Series C financing round to advance its pipeline of transformational medicines. The company also successfully completed a Phase 2a trial of ENV-101 in patients with idiopathic pulmonary fibrosis. Additionally, Endeavor BioMedicines appointed a new President and a new Chief Financial Officer.
Summaries written by the source dataset, not by us, and not checked.
biotechnology in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.